testosterone enanthate has been researched along with Anemia, Hypoplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farber, M; Smith, GB | 1 |
| Kessler, E; Levi, J; Turani, H; Zevin, D | 1 |
| Cassano, E; Castello, A; Cazzola, M; Coci, A; Danova, M; Giordano, M; Girino, M; Montecucco, CM; Riccardi, A; Ucci, G | 1 |
1 review(s) available for testosterone enanthate and Anemia, Hypoplastic
| Article | Year |
|---|---|
Therapeutic uses of androgenic agents.
Topics: Aged; Androgens; Anemia, Aplastic; Breast Neoplasms; Climacteric; Danazol; Female; Gonadal Dysgenesis; Humans; Hypogonadism; Infertility, Male; Liver Neoplasms; Male; Middle Aged; Oligospermia; Puberty, Delayed; Sexual Maturation; Testis; Testosterone; Vulvar Diseases | 1984 |
2 other study(ies) available for testosterone enanthate and Anemia, Hypoplastic
| Article | Year |
|---|---|
Hepatic lesions in patients on anabolic androgenic therapy.
Topics: Aged; Anabolic Agents; Anemia, Aplastic; Chemical and Drug Induced Liver Injury; Humans; Kidney Failure, Chronic; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Nandrolone; Oxymetholone; Testosterone | 1983 |
Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Topics: Acute Disease; Anemia, Aplastic; Anemia, Refractory; Bone Marrow; Cell Count; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Leukemia; Male; Myelodysplastic Syndromes; Testosterone; Time Factors | 1987 |